1	The	The	B-NP	DT	O	2	NMOD	-1
2	effects	effect	I-NP	NNS	O	0	ROOT	16	effects
3	of	of	B-PP	IN	O	2	NMOD	-1
4	radiation	radiation	B-NP	NN	O	3	PMOD	0
5	on	on	B-PP	IN	O	2	NMOD	-1
6	neovascularization	neovascularization	B-NP	NN	O	5	PMOD	3	neovascularization
7	in	in	B-PP	IN	O	2	NMOD	-1
8	a	a	B-NP	DT	O	10	NMOD	-1
9	rat	rat	I-NP	NN	O	10	NMOD	-1
10	model	model	I-NP	NN	O	7	PMOD	-1
11	.	.	O	.	O	2	P	-1

1	It	It	B-NP	PRP	O	2	SUB	-1
2	is	be	B-VP	VBZ	O	17	VMOD	-1
3	thought	think	I-VP	VBN	O	2	VC	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	radiation	radiation	B-NP	NN	O	6	NMOD	0
6	treatment	treatment	I-NP	NN	O	7	SUB	0
7	inhibits	inhibit	B-VP	VBZ	O	4	SBAR	18	inhibits
8	neovascularization	neovascularization	B-NP	NN	O	7	OBJ	3	neovascularization
9	of	of	B-PP	IN	O	8	NMOD	-1
10	recipient	recipient	B-NP	NN	O	13	NMOD	-1
11	and/or	and/or	I-NP	CC	O	13	NMOD	-1
12	graft	graft	I-NP	NN	O	13	NMOD	-1
13	tissues	tissue	I-NP	NNS	O	9	PMOD	-1
14	,	,	O	,	O	17	P	-1
15	and	and	O	CC	O	17	VMOD	-1
16	this	this	B-NP	DT	O	17	SUB	-1
17	may	may	B-VP	MD	O	0	ROOT	-1
18	account	account	I-VP	VB	O	17	VC	-1
19	in	in	B-PP	IN	O	18	VMOD	-1
20	part	part	B-NP	NN	O	19	PMOD	-1
21	for	for	B-PP	IN	O	19	PMOD	-1
22	abnormalities	abnormality	B-NP	NNS	O	21	PMOD	-1
23	in	in	B-PP	IN	O	22	NMOD	-1
24	wound	wound	B-NP	NN	O	25	NMOD	-1
25	healing	healing	I-NP	NN	O	23	PMOD	-1
26	associated	associate	B-VP	VBN	O	25	NMOD	0
27	with	with	B-PP	IN	O	26	VMOD	-1
28	radiation	radiation	B-NP	NN	O	29	NMOD	0
29	therapy	therapy	I-NP	NN	O	27	PMOD	0
30	.	.	O	.	O	17	P	-1

1	We	We	B-NP	PRP	O	2	SUB	-1
2	have	have	B-VP	VBP	O	0	ROOT	-1
3	examined	examine	I-VP	VBN	O	2	VC	-1
4	this	this	B-NP	DT	O	5	NMOD	-1
5	hypothesis	hypothesis	I-NP	NN	O	3	OBJ	-1
6	using	use	B-VP	VBG	O	5	NMOD	-1
7	a	a	B-NP	DT	O	8	NMOD	-1
8	model	model	I-NP	NN	O	6	OBJ	-1
9	that	that	B-NP	WDT	O	8	NMOD	-1
10	measures	measure	B-VP	VBZ	O	9	SBAR	-1
11	the	the	B-NP	DT	O	12	NMOD	-1
12	neovascularization	neovascularization	I-NP	NN	O	10	OBJ	3	neovascularization
13	of	of	B-PP	IN	O	12	NMOD	-1
14	an	an	B-NP	DT	O	17	NMOD	-1
15	implanted	implant	I-NP	VBN	O	17	NMOD	0
16	foreign	foreign	I-NP	JJ	O	17	NMOD	-1
17	material	material	I-NP	NN	O	13	PMOD	-1
18	.	.	O	.	O	2	P	-1

1	Expanded	Expand	B-NP	VBN	O	2	NMOD	-1
2	polytetrafluoroethylene	polytetrafluoroethylene	I-NP	NN	O	6	NMOD	-1
3	(	(	O	(	O	5	DEP	-1
4	PTFE	PTFE	B-NP	NN	O	5	DEP	-1
5	)	)	O	)	O	2	NMOD	-1
6	sheets	sheet	B-NP	NNS	O	7	SUB	-1
7	were	be	B-VP	VBD	O	0	ROOT	-1
8	implanted	implant	I-VP	VBN	O	7	VC	19	implanted
9	adjacent	adjacent	B-ADJP	JJ	O	8	VMOD	-1
10	to	to	B-PP	TO	O	9	AMOD	-1
11	both	both	O	CC	O	15	NMOD	-1
12	superficial	superficial	B-NP	JJ	O	15	NMOD	-1
13	epigastric	epigastric	I-NP	JJ	O	15	NMOD	-1
14	vascular	vascular	I-NP	JJ	O	15	NMOD	-1
15	pedicles	pedicle	I-NP	NNS	O	10	PMOD	-1
16	of	of	B-PP	IN	O	15	NMOD	-1
17	63	63	B-NP	CD	O	18	NMOD	-1
18	rats	rat	I-NP	NNS	O	16	PMOD	-1
19	distributed	distribute	B-VP	VBN	O	18	NMOD	-1
20	into	into	B-PP	IN	O	19	VMOD	-1
21	7	7	B-NP	CD	O	22	NMOD	-1
22	groups	group	I-NP	NNS	O	20	PMOD	-1
23	(	(	O	(	O	27	DEP	-1
24	n	n	B-NP	NN	O	26	SUB	-1
25	=	=	B-VP	SYM	O	26	VMOD	-1
26	7	7	B-NP	CD	O	27	DEP	-1
27	)	)	O	)	O	22	NMOD	-1
28	that	that	B-NP	WDT	O	22	NMOD	-1
29	differed	differ	B-VP	VBD	O	28	SBAR	-1
30	with	with	B-PP	IN	O	29	VMOD	-1
31	respect	respect	B-NP	NN	O	30	PMOD	-1
32	to	to	B-PP	TO	O	31	NMOD	-1
33	dose	dose	B-NP	NN	O	35	NMOD	-1
34	and	and	I-NP	CC	O	35	NMOD	-1
35	timing	timing	I-NP	NN	O	32	PMOD	-1
36	of	of	B-PP	IN	O	35	NMOD	-1
37	irradiation	irradiation	B-NP	NN	O	36	PMOD	-1
38	.	.	O	.	O	7	P	-1

1	Zero	Zero	B-NP	NN	O	14	SUB	-1
2	to	to	B-PP	TO	O	1	NMOD	-1
3	10	10	B-NP	CD	O	5	NMOD	-1
4	daily	daily	I-NP	JJ	O	5	NMOD	-1
5	fractions	fraction	I-NP	NNS	O	2	PMOD	-1
6	of	of	B-PP	IN	O	5	NMOD	-1
7	electron-beam	electron-beam	B-NP	NN	O	8	NMOD	-1
8	radiation	radiation	I-NP	NN	O	6	PMOD	0
9	(	(	O	(	O	13	DEP	-1
10	300	300	B-NP	CD	O	11	NMOD	-1
11	cGy	cGy	I-NP	NN	O	13	DEP	-1
12	each	each	B-NP	DT	O	11	NMOD	-1
13	)	)	O	)	O	8	NMOD	-1
14	were	be	B-VP	VBD	O	0	ROOT	-1
15	delivered	deliver	I-VP	VBN	O	14	VC	0
16	to	to	B-PP	TO	O	15	VMOD	-1
17	the	the	B-NP	DT	O	18	NMOD	-1
18	implant	implant	I-NP	NN	O	16	PMOD	-1
19	in	in	B-PP	IN	O	18	NMOD	-1
20	the	the	B-NP	DT	O	22	NMOD	-1
21	right	right	I-NP	JJ	O	22	NMOD	-1
22	groin	groin	I-NP	NN	O	19	PMOD	-1
23	,	,	O	,	O	14	P	-1
24	while	while	B-SBAR	IN	O	14	VMOD	-1
25	the	the	B-NP	DT	O	26	NMOD	-1
26	implant	implant	I-NP	NN	O	31	SUB	-1
27	in	in	B-PP	IN	O	26	NMOD	-1
28	the	the	B-NP	DT	O	30	NMOD	-1
29	left	left	I-NP	JJ	O	30	NMOD	-1
30	groin	groin	I-NP	NN	O	27	PMOD	-1
31	served	serve	B-VP	VBD	O	24	SBAR	-1
32	as	as	B-PP	IN	O	31	VMOD	-1
33	a	a	B-NP	DT	O	36	NMOD	-1
34	nonirradiated	nonirradiated	I-NP	JJ	O	36	NMOD	-1
35	internal	internal	I-NP	JJ	O	36	NMOD	-1
36	control	control	I-NP	NN	O	32	PMOD	0
37	.	.	O	.	O	14	P	-1

1	Unirradiated	Unirradiated	B-NP	JJ	O	2	NMOD	-1
2	animals	animal	I-NP	NNS	O	3	SUB	-1
3	showed	show	B-VP	VBD	O	0	ROOT	-1
4	equal	equal	B-NP	JJ	O	5	NMOD	-1
5	neovascularization	neovascularization	I-NP	NN	O	3	OBJ	3	neovascularization
6	of	of	B-PP	IN	O	5	NMOD	-1
7	both	both	B-NP	DT	O	8	NMOD	-1
8	implants	implant	I-NP	NNS	O	6	PMOD	-1
9	.	.	O	.	O	3	P	-1

1	Rats	Rat	B-NP	NNS	O	17	SUB	-1
2	that	that	B-NP	WDT	O	1	NMOD	-1
3	were	be	B-VP	VBD	O	2	SBAR	-1
4	irradiated	irradiate	I-VP	VBN	O	3	VC	19	irradiated
5	twice	twice	B-ADVP	RB	O	4	VMOD	-1
6	(	(	O	(	O	16	DEP	-1
7	single	single	B-NP	JJ	O	8	NMOD	-1
8	fractions	fraction	I-NP	NNS	O	16	DEP	-1
9	at	at	B-PP	IN	O	8	NMOD	-1
10	0	0	B-NP	CD	O	12	AMOD	-1
11	and	and	I-NP	CC	O	12	AMOD	-1
12	24	24	I-NP	CD	O	13	NMOD	-1
13	hours	hour	I-NP	NNS	O	9	PMOD	-1
14	after	after	B-PP	IN	O	8	NMOD	-1
15	implantation	implantation	B-NP	NN	O	14	PMOD	0
16	)	)	O	)	O	5	AMOD	-1
17	did	do	B-VP	VBD	O	0	ROOT	-1
18	not	not	I-VP	RB	O	17	VMOD	-1
19	show	show	I-VP	VB	O	17	VC	-1
20	a	a	B-NP	DT	O	22	NMOD	-1
21	significant	significant	I-NP	JJ	O	22	NMOD	-1
22	decrease	decrease	I-NP	NN	O	19	OBJ	18	decrease
23	in	in	B-PP	IN	O	22	NMOD	-1
24	the	the	B-NP	DT	O	25	NMOD	-1
25	neovascularization	neovascularization	I-NP	NN	O	23	PMOD	3	neovascularization
26	of	of	B-PP	IN	O	25	NMOD	-1
27	the	the	B-NP	DT	O	29	NMOD	-1
28	irradiated	irradiated	I-NP	JJ	O	29	NMOD	0
29	implant	implant	I-NP	NN	O	26	PMOD	-1
30	compared	compare	B-PP	VBN	O	19	VMOD	-1
31	with	with	B-PP	IN	O	30	PMOD	-1
32	the	the	B-NP	DT	O	35	NMOD	-1
33	contralateral	contralateral	I-NP	JJ	O	35	NMOD	-1
34	control	control	I-NP	NN	O	35	NMOD	0
35	implant	implant	I-NP	NN	O	31	PMOD	-1
36	.	.	O	.	O	17	P	-1

1	In	In	B-PP	IN	O	25	VMOD	-1
2	contrast	contrast	B-NP	NN	O	1	PMOD	-1
3	,	,	O	,	O	25	P	-1
4	the	the	B-NP	DT	O	5	NMOD	-1
5	implants	implant	I-NP	NNS	O	25	SUB	-1
6	that	that	B-NP	WDT	O	5	NMOD	-1
7	were	be	B-VP	VBD	O	6	SBAR	-1
8	irradiated	irradiate	I-VP	VBN	O	10	NMOD	0
9	three	three	B-NP	CD	O	10	NMOD	-1
10	times	time	I-NP	NNS	O	7	PRD	-1
11	(	(	O	(	O	24	DEP	-1
12	single	single	B-NP	JJ	O	13	NMOD	-1
13	fractions	fraction	I-NP	NNS	O	24	DEP	-1
14	at	at	B-PP	IN	O	13	NMOD	-1
15	0	0	B-NP	CD	O	21	NMOD	-1
16	,	,	I-NP	,	O	21	P	-1
17	24	24	I-NP	CD	O	21	NMOD	-1
18	,	,	O	,	O	21	P	-1
19	and	and	O	CC	O	21	NMOD	-1
20	48	48	B-NP	CD	O	21	NMOD	-1
21	hours	hour	I-NP	NNS	O	14	PMOD	-1
22	after	after	B-PP	IN	O	13	NMOD	-1
23	implantation	implantation	B-NP	NN	O	22	PMOD	0
24	)	)	O	)	O	10	NMOD	-1
25	demonstrated	demonstrate	B-VP	VBD	O	44	VMOD	-1
26	significantly	significantly	I-VP	RB	O	25	VMOD	-1
27	diminished	diminish	I-VP	VBN	O	25	VMOD	18	diminished
28	(	(	O	(	O	38	DEP	-1
29	greater	great	B-NP	JJR	O	30	AMOD	-1
30	than	than	I-NP	IN	O	32	NMOD	-1
31	25	25	I-NP	CD	O	30	AMOD	-1
32	percent	percent	I-NP	NN	O	34	NMOD	-1
33	,	,	O	,	O	34	P	-1
34	p	p	B-NP	NN	O	36	SUB	-1
35	less	less	B-ADJP	JJR	O	36	AMOD	-1
36	than	than	B-PP	IN	O	38	DEP	-1
37	0.05	0.05	B-NP	CD	O	36	AMOD	-1
38	)	)	O	)	O	39	NMOD	-1
39	neovascularization	neovascularization	B-NP	NN	O	27	OBJ	3	neovascularization
40	beyond	beyond	B-PP	IN	O	39	NMOD	-1
41	day	day	B-NP	NN	O	40	PMOD	-1
42	7	7	I-NP	CD	O	41	NMOD	-1
43	,	,	O	,	O	44	P	-1
44	whereas	whereas	O	IN	O	0	ROOT	-1
45	implants	implant	B-NP	NNS	O	46	SUB	-1
46	irradiated	irradiate	B-VP	VBD	O	44	VMOD	0
47	only	only	B-ADVP	RB	O	48	PMOD	-1
48	at	at	B-PP	IN	O	46	VMOD	-1
49	48	48	B-NP	CD	O	50	NMOD	-1
50	hours	hour	I-NP	NNS	O	48	PMOD	-1
51	after	after	B-PP	IN	O	46	VMOD	-1
52	implantation	implantation	B-NP	NN	O	53	SUB	0
53	did	do	B-VP	VBD	O	51	SBAR	-1
54	not	not	O	RB	O	53	VMOD	-1
55	.	.	O	.	O	44	P	-1

1	Interestingly	Interestingly	B-ADVP	RB	O	7	VMOD	-1
2	,	,	O	,	O	7	P	-1
3	neovascularization	neovascularization	B-NP	NN	O	7	SUB	3	neovascularization
4	of	of	B-PP	IN	O	3	NMOD	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	implants	implant	I-NP	NNS	O	4	PMOD	-1
7	irradiated	irradiate	B-VP	VBD	O	0	ROOT	0
8	with	with	B-PP	IN	O	7	VMOD	-1
9	10	10	B-NP	CD	O	10	NMOD	-1
10	fractions	fraction	I-NP	NNS	O	8	PMOD	-1
11	(	(	O	(	O	14	DEP	-1
12	3000	3000	B-NP	CD	O	13	NMOD	-1
13	cGy	cGy	I-NP	NN	O	14	DEP	-1
14	)	)	O	)	O	10	NMOD	-1
15	was	be	B-VP	VBD	O	7	VMOD	-1
16	not	not	I-VP	RB	O	15	VMOD	-1
17	significantly	significantly	I-VP	RB	O	15	VMOD	-1
18	decreased	decrease	I-VP	VBD	O	15	VMOD	18	decreased
19	compared	compare	B-PP	VBN	O	18	VMOD	-1
20	with	with	B-PP	IN	O	19	PMOD	-1
21	irradiation	irradiation	B-NP	NN	O	20	PMOD	-1
22	with	with	B-PP	IN	O	21	NMOD	-1
23	three	three	B-NP	CD	O	24	NMOD	-1
24	fractions	fraction	I-NP	NNS	O	22	PMOD	-1
25	(	(	O	(	O	28	DEP	-1
26	900	900	B-NP	CD	O	27	NMOD	-1
27	cGy	cGy	I-NP	NN	O	28	DEP	-1
28	)	)	O	)	O	24	NMOD	-1
29	.	.	O	.	O	7	P	-1

1	Irradiation	Irradiation	B-NP	NN	O	9	SUB	-1
2	delivered	deliver	B-VP	VBN	O	1	NMOD	0
3	before	before	B-PP	IN	O	2	VMOD	-1
4	implantation	implantation	B-NP	NN	O	3	PMOD	0
5	(	(	O	(	O	8	DEP	-1
6	900	900	B-NP	CD	O	7	NMOD	-1
7	cGy	cGy	I-NP	NN	O	8	DEP	-1
8	)	)	O	)	O	4	NMOD	-1
9	inhibited	inhibit	B-VP	VBD	O	0	ROOT	18	inhibited
10	neovascularization	neovascularization	B-NP	NN	O	9	OBJ	3	neovascularization
11	significantly	significantly	B-ADJP	RB	O	12	AMOD	-1
12	less	less	I-ADJP	JJR	O	9	VMOD	-1
13	than	than	B-PP	IN	O	12	AMOD	-1
14	the	the	B-NP	DT	O	16	NMOD	-1
15	same	same	I-NP	JJ	O	16	NMOD	-1
16	dose	dose	I-NP	NN	O	13	PMOD	-1
17	administered	administer	B-VP	VBN	O	16	NMOD	0
18	after	after	B-PP	IN	O	17	VMOD	-1
19	implantation	implantation	B-NP	NN	O	18	PMOD	0
20	.	.	O	.	O	9	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	results	result	I-NP	NNS	O	6	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	-1
4	this	this	B-NP	DT	O	5	NMOD	-1
5	study	study	I-NP	NN	O	3	PMOD	-1
6	suggest	suggest	B-VP	VBP	O	0	ROOT	-1
7	that	that	B-SBAR	IN	O	6	VMOD	-1
8	a	a	B-NP	DT	O	11	NMOD	-1
9	subclinical	subclinical	I-NP	JJ	O	11	NMOD	-1
10	cumulative	cumulative	I-NP	JJ	O	11	NMOD	-1
11	dose	dose	I-NP	NN	O	15	SUB	-1
12	of	of	B-PP	IN	O	11	NMOD	-1
13	900	900	B-NP	CD	O	14	NMOD	-1
14	cGy	cGy	I-NP	NN	O	12	PMOD	-1
15	is	be	B-VP	VBZ	O	7	SBAR	-1
16	the	the	B-NP	DT	O	17	NMOD	-1
17	threshold	threshold	I-NP	NN	O	15	PRD	-1
18	for	for	B-PP	IN	O	17	NMOD	-1
19	impaired	impaired	B-NP	JJ	O	21	NMOD	18	impaired
20	tissue	tissue	I-NP	NN	O	21	NMOD	-1
21	revascularization	revascularization	I-NP	NN	O	18	PMOD	3	revascularization
22	provided	provide	B-VP	VBD	O	7	DEP	-1
23	that	that	B-SBAR	IN	O	22	VMOD	-1
24	treatment	treatment	B-NP	NN	O	25	SUB	0
25	is	be	B-VP	VBZ	O	23	SBAR	-1
26	delivered	deliver	I-VP	VBN	O	25	VC	0
27	immediately	immediately	B-ADVP	RB	O	26	VMOD	-1
28	after	after	B-PP	IN	O	26	VMOD	-1
29	implantation	implantation	B-NP	NN	O	28	PMOD	0
30	over	over	B-PP	IN	O	26	VMOD	-1
31	a	a	B-NP	DT	O	33	NMOD	-1
32	48-hour	48-hour	I-NP	JJ	O	33	NMOD	-1
33	interval	interval	I-NP	NN	O	30	PMOD	-1
34	.	.	O	.	O	6	P	-1

